Skip to content
Sign in

Business opportunities

Who each startup should sell to, sell through, build with, enter a market with or raise from, read from the whole network. Every opportunity comes with its reasoning, the evidence and a first step.

SWC 2026 Finalist

Hormony

Mexican menopause FemTech pairing saliva hormone kits with AI symptom tracking, already retailing in Hong Kong through Mannings pharmacies.

Open the dossier
Opportunities
4
High confidence
070% and above
Counterparts
4startups and investors
  • Distribution 1
  • Co-development 2
  • Investors 1

Distribution1

A channel or customer base to reach together

Become the testing input for IKI's menopause lifestyle programmes

IKI Health lets clinicians prescribe personalised lifestyle programmes, notably for menopause, and needs patient data to personalise them. Hormony's kit and symptom tracker can feed that data, giving Hormony a clinician-led channel in Spain/Europe.

40%confidence

Evidence from the records

  • “lets healthcare professionals prescribe personalized lifestyle medicine programs (notably for menopause)”
  • “Saliva hormone test kit combined with digital tools and AI to track and interpret symptoms.”
If it works
A bundled clinician offer in Spain and a first European market.
First step
Propose to IKI a data-integration pilot with 50 patients.

Co-development2

An integration or joint product

Joint 'hair and hormones' campaign in Hong Kong

Hair thinning is a common menopause symptom and HairCoSys runs AI scalp diagnostics in Hong Kong salons. Cross-referrals between salons and Mannings pharmacies serve the same consumer.

35%confidence

Evidence from the records

  • “Tools used by salons in Hong Kong (Toni & Guy, fufu, Chalachol); rollout announced across the Powell Group's 70 salons.”
  • “Kit sold in Hong Kong through the Mannings pharmacy chain.”
If it works
Co-marketing reach in 70 salons and pharmacies.
First step
Contact HairCoSys's CEO to scope a joint promotion.

Share an at-home women's-health testing platform with Arelis

Arelis is developing an at-home urine test for endometriosis with ML analysis; Hormony runs at-home saliva testing with AI interpretation. Sharing the consumer app, sample logistics and pharmacy channels could reduce costs for both.

15%confidence

Evidence from the records

  • “Machine learning/AI analysis of a urine sample to build an endometriosis risk profile.”
  • “AI helps track and interpret symptoms and saliva hormone test results.”
If it works
A broader women's-health test portfolio for pharmacy partners.
First step
Arrange a founder call to explore a shared app/channel.

Investors1

A fund whose thesis fits

Pitch Innogen via Pulster.ai

Innogen invests at pre-seed/seed in Latin American HealthTech and is cited as a Pulster.ai investor in the network.

20%confidence

Evidence from the records

  • “Cacao Capital, MANA Tech (PitchBook); the site also cites Innogen Capital, Barrilete Ventures, Escala LATAM”
  • “Pharmacy distribution”
If it works
A LatAm seed investor to fund validation and expansion.
First step
Ask Pulster.ai's founders for an intro to Innogen.

Analyst reading of 21 Nov 2026, from the public record of the network. Method: analyst-ai

Most promising across the network

587 opportunities analysed
  1. Critical Medical DeviceswithLove LifesciencesPeers
    Share drug-delivery device lessons with Love Lifesciences

    Both are US pre-seed drug-delivery device companies founded around a clinical pain point. Exchanging contract manufacturer, regulatory consultant and pharma-partnering contacts saves both time and money.

    30%
  2. Roam TechnologieswithByonyksPeers
    Learn from Byonyks' 2025 FDA class II clearance and US launch set-up

    Byonyks obtained FDA 510(k) clearance for a home-therapy device and is setting up US infrastructure, the exact path Roam must follow. A founder exchange can shorten Roam's regulatory and DME launch planning.

    30%
  3. Lampsy HealthwithLegit.HealthPeers
    Learn from Legit.Health's medical-device certification path

    Legit.Health took an AI medical device through CE marking with an ISO 13485 quality system in Iberia; Lampsy faces the same regulatory steps. A founder exchange shortens the learning curve.

    30%
  4. AlgatekwithAtoz Carbon Cycle PlatformPeers
    Regional microalgae alliance for Malaysia

    Atoz builds nature-based carbon solutions with microalgae in Malaysia but has no public traction; Algatek has installed units at Indonesian SOEs. Sharing technology, MRV methods and possibly licensing Algatek units into Malaysia would give both a bigger regional story.

    25%
  5. Learn from a deployed microalgae business next door

    Algatek has leased microalgae units to Indonesian SOEs and claims IoT-monitored capture; Atoz has a prototype. Licensing or co-selling Algatek's MicroForest in Malaysia could give Atoz an immediate product while it builds its platform.

    25%
  6. Love LifescienceswithCritical Medical DevicesPeers
    Share FDA and QMS learnings between two pre-clearance drug-delivery devices

    Both companies are pre-FDA drug-delivery device makers founded by clinicians. Sharing regulatory consultants, QMS templates and test labs reduces cost for both.

    25%
  7. ZymoChemwithYeast Bay BioPeers
    Davis fermentation network and scale-up playbook

    ZymoChem's CEO trained at UC Davis, where Yeast Bay Bio was founded in 2025. Sharing contract-fermentation contacts, scale-up lessons and DOE/grant experience is low cost and high value for a seed-stage fermentation company.

    25%
  8. LainTechwithBaniqlPeers
    Battery-metals alliance between two atmospheric leaching processes

    Baniql produces battery-grade nickel MHP from Indonesian laterites at low temperature and pressure; Lain Tech treats sulfides containing cobalt and nickel. Together they can present battery offtakers a complementary low-carbon hydrometallurgy portfolio and share know-how on catalysts and scale-up.

    25%
  9. Amass BiosystemswithRegenratePeers
    Borrow Regenrate’s contract-farming model for intercrops

    Regenrate monetises the intercrop period in France with free seed and guaranteed purchase prices — the same farmer-economics problem Amass must solve. Its contract design is a template for Amass' farmer offer.

    20%
  10. BILIXwithPleryon TherapeuticsPeers
    Exchange on polymer-drug CMC and Asian licensing

    Both companies develop polymer-based therapeutics at Series A in Asia. Sharing CMC suppliers, regulatory strategy and licensing contacts reduces cost and time for both.

    20%
  11. Pleryon TherapeuticswithBioSapienPeers
    Compare local-delivery regulatory playbooks

    Both companies build localised, extended-release delivery platforms (BioSapien in oncology implants, Pleryon in ophthalmology). Sharing regulatory and CMC learnings on biodegradable delivery systems reduces costly missteps.

    20%
  12. RegenratewithAmass BiosystemsPeers
    Exchange intercrop-for-bioenergy playbooks

    Amass grows a bioenergy crop alongside corn for biomass; Regenrate grows camelina between crops for biofuel. Both sell farmer income diversification to energy buyers and can share off-take and agronomy learnings across EU/US.

    20%
  13. FluvwithTausiPeers
    Share the gig-provider OS playbook

    Tausi runs an AI-powered operating system for independent beauticians with verified providers and a commission model. Fluv faces the same supply-side problem with pet-sitters; exchanging verification, training and retention practices is useful for both.

    15%
  14. PromptendwithNeurath AIPeers
    AI reliability peer exchange

    Both address trust in AI outputs (Promptend for generated code, Neurath for model predictions) and sell to risk-averse engineering buyers; sharing go-to-market learnings on assurance products is useful.

    15%
  15. PsychoTechwithPromptendPeers
    Moldovan finalist cohort coordination

    Both represent Moldova at the SWC final; pooling travel, investor meetings and Startup Moldova support reduces cost, and PsychoTech could pilot Promptend on its client code.

    15%
  16. ShopperoowithPardon AIPeers
    Benchmark against Pardon AI's profitability agents

    Pardon AI sells AI agents that optimise revenue and margins for retail and food service and has been through Techstars. A founder exchange clarifies positioning and possible specialisation (pricing/assortment vs broader profitability).

    15%
  17. VIEROC AIwithWiseUnitPeers
    Exchange voice-agent and chat-agent learnings with WiseUnit

    WiseUnit sells an AI phone receptionist; VIEROC focuses on chat agents. Comparing pricing, churn and model costs, or white-labelling each other's channel, could help both small teams.

    15%
  18. SchoolACEwithKetzaiPeers
    Learn from Ketzai’s path to 40,000 teachers

    Ketzai solved teacher acquisition for AI lesson planning by aligning with official curricula; SchoolACE can learn its playbook and potentially share content tooling for Spanish-speaking US classrooms.

    15%

Similar profiles

Compatibility score with Hormony

Scored on needs and offers, market bridge, customer potential, sector synergy and stage. Open a profile to see each dimension.